Related Experiment Video
Updated: Dec 15, 2025

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
Seven-Year Case-Control Study in California of Risk Factors for Infant Botulism
Mayuri V Panditrao1, Haydee A Dabritz1, N Neely Kazerouni1
1Infant Botulism Treatment and Prevention Program, California Department of Public Health, Richmond, CA.
Insights
Infant botulism risk factors in California included slower intestinal transit time (≤1 bowel movement/day) in infants under two months old. Other identified factors varied by control group and infant age, with few consistent associations found.
Area of Science:
- Pediatric Infectious Diseases
- Epidemiology
- Public Health
Background:
- Infant botulism is an intestinal infectious form of human botulism.
- The condition was first recognized in California in 1976.
Purpose of the Study:
- To identify potential risk factors for infant botulism.
- Investigate factors in the years following its initial recognition.
Main Methods:
- Case-control study involving 159 infant botulism cases and 318 healthy controls.
- Comprehensive questionnaires (>300 factors) and age-stratified logistic regression analyses were used.
- Two control groups were utilized: neighborhood controls and county controls.
Main Results:
- Slower intestinal transit time (≤1 bowel movement/day) was associated with infant botulism, except in the ≤2-month-old county controls group.
- Risk factors differed based on infant age and the type of control group used.
- Factors like birth order >1, cesarean delivery, and windy residence area were associated with illness in some analyses.
Conclusions:
- Slower intestinal transit time is a significant risk factor for infant botulism.
- Few consistent physiologic, environmental, or maternal factors were identified across all analyses.
- The study highlights the complexity of identifying risk factors for infant botulism.
Objective:
To ascertain possible risk factors for infant botulism, the intestinal infectious form of human botulism, in the years immediately following its initial recognition in California in 1976.
Study Design:
Parents of 159 California laboratory-confirmed cases of infant botulism from 1976 to 1983 and 318 healthy controls were interviewed using a comprehensive (>300 factors) questionnaire. "Neighborhood controls" (n = 184) were matched on date of birth, sex, race/ethnicity, and neighborhood of residence. "County controls" (n = 134) were matched only on date of birth, sex, and county of residence. Age-stratified bivariate and multivariate conditional logistic regression analyses were performed using SAS.
Results:
All cases required hospitalization. Bivariate analyses identified several risk factors that in multivariate analyses were not significant. In multivariate analyses, risk factors differed with stratification by age. For the ≤2 month-old neighborhood controls comparison, birth order >1, cesarean delivery, ≤1 bowel movements (BMs) per day, and windy residence area were associated with illness hospitalization, and for the county controls comparison, only pacifier use was associated. For the <2 month-old neighborhood controls comparison, <1 bowel movements (BMs) per day, cesarean delivery, birth order >1, and windy residence area were associated with illness hospitalization, and for the county controls comparison, pets in the home was an additional risk factor.
Conclusions:
With the exception of the ≤2-month-old county controls group, slower intestinal transit time (≤1 BM/d) was associated with illness. Otherwise, our case-control investigation identified few physiologic, environmental, and maternal factors associated with infant botulism hospitalization in California.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Teratogenicity
Drug Dosing: Infants and Children

